Mark D. Reeth is Gen Counsel&VP Corp Compliance at SALIX PHARMACEUTICALS LTD (SLXP). They have made 2 open-market trades across 1 company since 2008, most recently 2012-05-01.
CIK 0001399353
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SLXP | 33,668 | — |
Shares reported on the most recent Form 4, priced at the 2012-05-03 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SLXP | SELL · 10b5-1 | 2012-05-01 | 2012-05-03 | $48.91 | $49K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2011-07-05 | 2011-07-06 | $40.32 | $297K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2011-05-16 | 2011-05-17 | $39.84 | $135K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2010-06-14 | 2010-06-15 | $36.24 | $155K | N/A | N/A | N/A |
| SLXP | SELL · 10b5-1 | 2010-05-17 | 2010-05-19 | $37.38 | $126K | N/A | N/A | N/A |
| SLXP | SELL | 2009-11-23 | 2009-11-24 | $23.64 | $80K | N/A | N/A | N/A |
| SLXP | SELL | 2008-05-01 | 2008-05-05 | $7.16 | $12K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.